{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:44Z","timestamp":1790710964321,"version":"4.1.0"},"reference-count":228,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.03097","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:24:56Z","timestamp":1544574296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant"],"prefix":"10.3389","volume":"9","author":[{"given":"Diego R.","family":"Hijano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall T.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"","journal-title":"Pediatrics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e20172550","DOI":"10.1542\/peds.2017-2550","article-title":"Recommendations for prevention and control of influenza in children, 2018\u20132019","volume":"140","year":"2018","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/bmt.2013.100","article-title":"Outcomes of hematopoietic stem cell transplant recipients with rhinovirus infection: a matched, case-control study","volume":"48","author":"Abandeh","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B5","unstructured":"Inhaled ALX-0171: Phase I\/IIa Study in 53 hospitalised RSV-Infected Children [Online]2016"},{"key":"B6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1128\/cvi.00618-14","article-title":"Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children","volume":"22","author":"Adderson","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1128\/jvi.00998-13","article-title":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/infdis\/jix203","article-title":"Characterizing the cellular immune response to parainfluenza virus 3","volume":"216","author":"Aguayo-Hiraldo","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/jpids\/piu025","article-title":"The medicaid cost of palivizumab","volume":"4","author":"Ambrose","year":"2015","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B10","first-page":"583","article-title":"Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine","volume":"64","author":"Appiah","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1128\/jcm.01516-15","article-title":"FilmArray respiratory panel assay: comparison of nasopharyngeal swabs and bronchoalveolar lavage samples","volume":"53","author":"Azadeh","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/qco.0000000000000456","article-title":"Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients","volume":"31","author":"Baugh","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/infdis\/jis487","article-title":"Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology","volume":"206","author":"Beck","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2015_116","article-title":"Evaluation of the activity of influenza and influenza-like viruses in the epidemic season 2013\/2014","volume":"857","author":"Bednarska","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"B16","unstructured":"BiopharmaA. Ansun BioPharma Announces Breakthrough Designation for Its Experimental Drug DAS181 [Online]2017"},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/509930","article-title":"Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients","volume":"44","author":"Boeckh","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1164\/rccm.201008-1230ED","article-title":"Evaluation of therapeutics for RSV: an important step forward","volume":"182","author":"Boeckh","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00006454-200002000-00006","article-title":"Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants","volume":"19","author":"Buckingham","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/aac.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S326","DOI":"10.1093\/cid\/cir047","article-title":"Multiplex PCR and emerging technologies for the detection of respiratory pathogens","volume":"52","author":"Caliendo","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/cid\/civ272","article-title":"Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant","volume":"61","author":"Campbell","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/infdis\/jix489","article-title":"Prefusion F, postfusion F, G antibodies, and disease severity in infants and young children with acute respiratory syncytial virus infection","volume":"216","author":"Capella","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/infdis\/jir561","article-title":"Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer","volume":"204","author":"Carr","year":"","journal-title":"J. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/INF.0b013e3181ff863b","article-title":"Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer","volume":"30","author":"Carr","year":"","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/infdis\/jiw624","article-title":"Development of a global respiratory severity score for respiratory syncytial virus infection in infants","volume":"215","author":"Caserta","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1182\/blood-2009-11-255455","article-title":"How I treat influenza in patients with hematologic malignancies","volume":"115","author":"Casper","year":"2010","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/tid.12177","article-title":"DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation","volume":"16","author":"Chalkias","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"B29","first-page":"511","article-title":"Status of lung transplant recipients surviving beyond five years","volume":"16","author":"Chaparro","year":"1997","journal-title":"J. Heart Lung Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/tid.12551","article-title":"Aerosolized ribavirin: the most expensive drug for pneumonia","volume":"18","author":"Chemaly","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.md.0000232560.22098.4e","article-title":"Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center","volume":"85","author":"Chemaly","year":"2006","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1182\/blood-2011-08-371112","article-title":"The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation","volume":"119","author":"Chemaly","year":"2012","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1093\/cid\/ciu623","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"59","author":"Chemaly","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1093\/cid\/cir501","article-title":"Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation","volume":"53","author":"Chen","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1182\/blood-2010-11-319186","article-title":"Differences in clinical outcomes after 2009 influenza A\/H1N1 and seasonal influenza among hematopoietic cell transplant recipients","volume":"117","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/irv.12375","article-title":"Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children","volume":"10","author":"Chu","year":"2016","journal-title":"Influenza Other Respir. Viruses"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e00737","DOI":"10.1128\/aac.00737-17","article-title":"Preclinical characterization of PC786, an inhaled small-molecule respiratory syncytial virus L protein polymerase inhibitor","volume":"61","author":"Coates","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","first-page":"26","article-title":"Respiratory viral infections in immunocompetent and immunocompromised persons","volume":"25","author":"Couch","year":"1997","journal-title":"Am. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1750-2659.2010.00144.x","article-title":"Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients","volume":"4","author":"Couturier","year":"2010","journal-title":"Influenza Other Respir. Viruses"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.bbmt.2014.11.255","article-title":"Oral ribavirin for the treatment of respiratory syncytial virus infection in allogeneic stem cell transplant recipients-utility of the immunodeficiency scoring index for risk stratification","volume":"21","author":"Damlaj","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1086\/521912","article-title":"Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation","volume":"45","author":"de Fontbrune","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/cid\/ciu632","article-title":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients","volume":"59","author":"de Jong","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/aac.00793-07","article-title":"Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus","volume":"52","author":"Deffrasnes","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1203\/01.Pdr.0000145255.86117.6a","article-title":"Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load","volume":"56","author":"Devincenzo","year":"2004","journal-title":"Pediatr. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0022-3476(03)00213-0","article-title":"Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody","volume":"143","author":"DeVincenzo","year":"2003","journal-title":"J. Pediatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1086\/344331","article-title":"Relationship between respiratory syncytial virus load and illness severity in children","volume":"186","author":"DeVincenzo","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1086\/430008","article-title":"Respiratory syncytial virus load predicts disease severity in previously healthy infants","volume":"191","author":"DeVincenzo","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"DeVincenzo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/aac.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1111\/tid.12045","article-title":"DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient","volume":"15","author":"Drozd","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"19s","DOI":"10.1053\/bbmt.2001.v7.pm11777100","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections","volume":"7","author":"Dykewicz","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1002\/cncr.30599","article-title":"Burden of human metapneumovirus infections in patients with cancer: risk factors and outcomes","volume":"123","author":"El Chaer","year":"2017","journal-title":"Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/infdis\/jir494","article-title":"Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children","volume":"204","author":"El Saleeby","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1542\/peds.2007-1102","article-title":"Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age","volume":"121","author":"El Saleeby","year":"2008","journal-title":"Pediatrics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/tid.12054","article-title":"European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN","volume":"15","author":"Engelhard","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"B60","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.bbmt.2010.11.008","article-title":"Viral infections in immunocompromised patients","volume":"17","author":"Englund","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2s","DOI":"10.1053\/bbmt.2001.v7.pm11777101","article-title":"Diagnosis and epidemiology of community-acquired respiratory virus infections in the immunocompromised host","volume":"7","author":"Englund","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B63","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0022-3476(94)70026-5","article-title":"High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection","volume":"125","author":"Englund","year":"1994","journal-title":"J. Pediatr."},{"key":"B64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(05)80554-2","article-title":"High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection","volume":"117","author":"Englund","year":"1990","journal-title":"J. Pediatr."},{"key":"B65","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/JCM.34.7.1649-1653.1996","article-title":"Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults","volume":"34","author":"Englund","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"B66","first-page":"30","article-title":"Diagnosis of respiratory viruses in cancer and transplant patients","volume":"19","author":"Englund","year":"1999","journal-title":"Curr. Clin. Top. Infect. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1086\/504268","article-title":"Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses","volume":"193","author":"Erard","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbmt.2010.07.018","article-title":"Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences","volume":"17","author":"Espinosa-Aguilar","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e12657","DOI":"10.1111\/tid.12657","article-title":"Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons","volume":"19","author":"Falsey","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"B70","unstructured":"FDA Approves New Drug to Treat Influenza [Online]. U.S. Food and Drug Administration2018"},{"key":"B71","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm. Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jpids\/pix051","article-title":"A multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients","volume":"7","author":"Fisher","year":"2017","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"B73","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.1016\/j.bbmt.2017.12.451","article-title":"Impact of ribavirin formulation and host risk factors on 90-day mortality in Hematopoietic Cell Transplant (HCT) patients with RSV infection","volume":"24","author":"Foolad","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B74","doi-asserted-by":"publisher","first-page":"S189","DOI":"10.1016\/j.bbmt.2016.12.367","article-title":"Use of oral ribavirin for the treatment of RSV infections in Hematopoietic Cell Transplant (HCT) recipients","volume":"23","author":"Foolad","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B75","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3851\/imp2957","article-title":"Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS)","volume":"20","author":"Fraaij","year":"2015","journal-title":"Antivir. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jcv.2010.05.007","article-title":"Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection","volume":"48","author":"Franz","year":"2010","journal-title":"J. Clin. Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/jmv.23455","article-title":"Association of the CT values of real-time PCR of viral upper respiratory tract infection with clinical severity, Kenya","volume":"85","author":"Fuller","year":"2013","journal-title":"J. Med. Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol. Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcv.2007.10.018","article-title":"Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy","volume":"41","author":"Gerna","year":"2008","journal-title":"J. Clin. Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1702228","article-title":"Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin","volume":"25","author":"Ghosh","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"B81","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1128\/cmr.00075-13","article-title":"Whole-genome sequencing in outbreak analysis","volume":"28","author":"Gilchrist","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-0031-1283283","article-title":"Update on rhinovirus and coronavirus infections","volume":"32","author":"Greenberg","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/jcm.01881-16","article-title":"Rapid metagenomic next-generation sequencing during an investigation of hospital-acquired human parainfluenza virus 3 infections","volume":"55","author":"Greninger","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1203\/00006450-198703000-00013","article-title":"Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat","volume":"21","author":"Gruber","year":"1987","journal-title":"Pediatr. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1399-3062.2012.00718.x","article-title":"Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients","volume":"14","author":"Guzm\u00e1n-Suarez","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/s1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.vaccine.2016.04.053","article-title":"Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection","volume":"34","author":"Hakim","year":"","journal-title":"Vaccine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/cncr.29833","article-title":"Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia","volume":"122","author":"Hakim","year":"","journal-title":"Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/jcm.01944-14","article-title":"Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease","volume":"52","author":"Hakki","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/nejm200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-642-38919-1_2","article-title":"Clinical and epidemiologic features of respiratory syncytial virus","volume":"372","author":"Hall","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B92","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/infdis\/162.6.1283","article-title":"Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children","volume":"162","author":"Hall","year":"1990","journal-title":"J. Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10156-012-0429-0","article-title":"Intrahost emergent dynamics of oseltamivir-resistant virus of pandemic influenza A (H1N1) 2009 in a fatally immunocompromised patient","volume":"18","author":"Hamada","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1128\/jcm.00538-12","article-title":"Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods","volume":"50","author":"Hammond","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jcv.2011.12.020","article-title":"Comparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised children","volume":"53","author":"Hayden","year":"2012","journal-title":"J. Clin. Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"B100","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1182\/asheducation-2013.1.342","article-title":"T-cell therapy for viral infections","volume":"2013","author":"Heslop","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.09.014","article-title":"Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery","volume":"127","author":"Heylen","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cid\/cis844","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/9781555819040.ch11","article-title":"\u201cRespiratory RNA Viruses,\u201d","volume-title":"Diagnostic Microbiology of the Immunocompromised Host, 2nd Edn","author":"Hodinka","year":"2016"},{"key":"B104","first-page":"336","article-title":"Human metapneumovirus in haematopoietic stem cell transplantation recipients: a case series and review of the diagnostic and therapeutic approach","volume":"74","author":"Hoppe","year":"2016","journal-title":"Neth. J. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/infdis\/jiy335","article-title":"Use of whole-genome sequencing in the investigation of a nosocomial influenza virus outbreak","volume":"218","author":"Houlihan","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.bbmt.2015.06.015","article-title":"Significant transplantation-related mortality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation","volume":"21","author":"Hutspardol","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/s1473-3099(13)70287-1","article-title":"Optimum timing of oseltamivir: lessons from Bangladesh","volume":"14","author":"Ison","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00001432-200208000-00002","article-title":"Viral infections in immunocompromised patients: what's new with respiratory viruses?","volume":"15","author":"Ison","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Issa","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/cmr.00077-12","article-title":"Human rhinoviruses","volume":"26","author":"Jacobs","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/17476348.2017.1338567","article-title":"Respiratory syncytial virus: prospects for new and emerging therapeutics","volume":"11","author":"Jorquera","year":"2017","journal-title":"Expert Rev. Respir. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jinf.2008.10.003","article-title":"Clinical characterization of human metapneumovirus infection among patients with cancer","volume":"57","author":"Kamboj","year":"2008","journal-title":"J. Infect."},{"key":"B113","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/171.5.1107","article-title":"A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children","volume":"171","author":"Karron","year":"","journal-title":"J. Infect. Dis."},{"key":"B114","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"","journal-title":"J. Infect. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.bbmt.2010.03.011","article-title":"Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab","volume":"16","author":"Kassis","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B116","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1399-3062.2008.00362.x","article-title":"Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Khanna","year":"2009","journal-title":"Transpl. Infect. Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/irv.12503","article-title":"The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin","volume":"11","author":"Kim","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"B118","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-2007-976494","article-title":"Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection","volume":"28","author":"Kim","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/infdis\/jit832","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease","volume":"209","author":"Kim","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B121","first-page":"97","article-title":"High dose-short duration ribavirin aerosol treatment\u2013a review","volume":"66","author":"Knight","year":"1991","journal-title":"Bull. Int. Union Tuberc. Lung Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"B123","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2017.05.010","article-title":"The role of next generation sequencing in infection prevention in human parainfluenza virus 3 infections in immunocompromised patients","volume":"92","author":"Kothari","year":"2017","journal-title":"J. Clin. Virol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.emc.2017.12.006","article-title":"Bronchiolitis: From practice guideline to clinical practice","volume":"36","author":"Kou","year":"2018","journal-title":"Emerg. Med. Clin. North Am."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A five-year prospective multi-center evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cll.2014.02.010","article-title":"Antiviral resistance in influenza viruses: laboratory testing","volume":"34","author":"Laplante","year":"2014","journal-title":"Clin. Lab. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3851\/imp1722","article-title":"Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia","volume":"16","author":"Lee","year":"2011","journal-title":"Antivir. Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/imr.12138","article-title":"Antiviral T-cell therapy","volume":"258","author":"Leen","year":"2014","journal-title":"Immunol. Rev."},{"key":"B129","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1469-0691.2012.03971.x","article-title":"Vaccination of immunocompromised patients","volume":"18","author":"Ljungman","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"B131","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/sj.bmt.1703139","article-title":"Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Ljungman","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B132","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/petr.12383","article-title":"Human rhinovirus C infections in pediatric hematology and oncology patients","volume":"19","author":"Loria","year":"2015","journal-title":"Pediatr. Transplant."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/cid\/cis636","article-title":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09","volume":"55","author":"Louie","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e40261","DOI":"10.1371\/journal.pone.0040261","article-title":"Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09","volume":"7","author":"Louie","year":"","journal-title":"PLoS ONE"},{"key":"B135","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/322628","article-title":"Respiratory virus infections in pediatric hematopoietic stem cell transplantation","volume":"33","author":"Luj\u00e1n-Zilbermann","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1128\/jvi.01807-09","article-title":"A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants","volume":"84","author":"Lukens","year":"2010","journal-title":"J. Virol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.bmt.1705159","article-title":"The benefit of influenza vaccination after bone marrow transplantation","volume":"36","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"B138","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/pbc.23390","article-title":"Impact of parainfluenza virus infection in pediatric cancer patients","volume":"59","author":"Maeng","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1128\/cmr.00037-07","article-title":"Detection of respiratory viruses by molecular methods","volume":"21","author":"Mahony","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"B140","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10408363.2011.640976","article-title":"Molecular diagnosis of respiratory virus infections","volume":"48","author":"Mahony","year":"2011","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1128\/aac.01086-13","article-title":"Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens","volume":"57","author":"Marjuki","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B142","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.bbmt.2005.07.007","article-title":"Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies","volume":"11","author":"Martino","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B143","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1183\/13993003\/erj.42.Suppl_57.1493","article-title":"Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial","volume":"42","author":"Matz","year":"2013","journal-title":"Eur. Respir. J."},{"key":"B144","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-642-38919-1_4","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1413456","article-title":"Viral bronchiolitis in children","volume":"374","author":"Meissner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.vaccine.2016.09.026","article-title":"Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection","volume":"35","author":"Mejias","year":"2017","journal-title":"Vaccine"},{"key":"B147","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.vaccine.2016.09.045","article-title":"Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development","volume":"35","author":"Melero","year":"2017","journal-title":"Vaccine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1182\/blood-2009-09-244152","article-title":"Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients","volume":"115","author":"Milano","year":"2010","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/jac\/dkq100","article-title":"Targeting pandemic influenza: a primer on influenza antivirals and drug resistance","volume":"65","author":"Moss","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e12849","DOI":"10.1371\/journal.pone.0012849","article-title":"Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable","volume":"5","author":"Mulrennan","year":"2010","journal-title":"PLoS ONE"},{"key":"B152","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/blood.v98.3.573","article-title":"Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome","volume":"98","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/s0140-6736(03)14854-4","article-title":"Influenza","volume":"362","author":"Nicholson","year":"2003","journal-title":"Lancet"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix093","article-title":"Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state","author":"Ogimi","year":"","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"B156","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/infdis\/jix264","article-title":"Prolonged shedding of human coronavirus in hematopoietic cell transplant recipients: risk factors and viral genome evolution","volume":"216","author":"Ogimi","year":"","journal-title":"J. Infect. Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cid\/cix160","article-title":"Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"64","author":"Ogimi","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.bbmt.2018.07.006","article-title":"Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients","volume":"24","author":"Ogimi","year":"","journal-title":"Biol. Blood Marrow Transplant"},{"key":"B159","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3201\/eid2101.141006","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14","volume":"21","author":"Okomo-Adhiambo","year":"2015","journal-title":"Emerging Infect. Dis."},{"key":"B160","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/irv.12215","article-title":"Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria","volume":"8","author":"Okomo-Adhiambo","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"B161","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/irv.12051","article-title":"Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors","volume":"7","author":"Okomo-Adhiambo","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"B162","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.bmt.1701813","article-title":"Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model","volume":"24","author":"Ottolini","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B164","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/rmv.651","article-title":"The distinguishing features of human metapneumovirus and respiratory syncytial virus","volume":"20","author":"Papenburg","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.bbmt.2017.12.471","article-title":"Oral Ribavirin for the Treatment of Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections in Hematology Patients and Stem Cell Transplant (SCT) Recipients at a Nci-Designated Cancer Center","volume":"24","author":"Pasikhova","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2006-12-060343","article-title":"Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection","volume":"110","author":"Peck","year":"2007","journal-title":"Blood"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1128\/jcm.03368-12","article-title":"Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses","volume":"51","author":"Popowitch","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/187152607780090757","article-title":"Antiviral strategies against human coronaviruses","volume":"7","author":"Pyrc","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"B169","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(97)00011-9","article-title":"Infection control of nosocomial respiratory viral disease in the immunocompromised host","volume":"102","author":"Raad","year":"1997","journal-title":"Am. J. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1128\/jcm.02582-10","article-title":"Comparison of two multiplex methods for detection of respiratory viruses: filmArray RP and xTAG RVP","volume":"49","author":"Rand","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3201\/eid1704.101429","article-title":"H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients","volume":"17","author":"Renaud","year":"","journal-title":"Emerg. Infect. Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/QCO.0b013e3283480440","article-title":"Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients","volume":"24","author":"Renaud","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B173","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3851\/imp2060","article-title":"Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients","volume":"17","author":"Renaud","year":"2012","journal-title":"Antivir. Ther."},{"key":"B174","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/02770903.2011.582660","article-title":"Emergence of oseltamivir-resistant pandemic H1N1 in an immunocompetent child with severe status asthmaticus","volume":"48","author":"Renaud","year":"","journal-title":"J. Asthma"},{"key":"B175","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jcv.2011.05.019","article-title":"Emerging oseltamivir resistance in seasonal and pandemic influenza A\/H1N1","volume":"52","author":"Renaud","year":"","journal-title":"J. Clin. Virol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1399-3062.2010.00582.x","article-title":"Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir","volume":"12","author":"Renaud","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.bbmt.2013.05.005","article-title":"Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients","volume":"19","author":"Renaud","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B178","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tim.2017.09.009","article-title":"Clinical potential of prefusion RSV F-specific antibodies","volume":"26","author":"Rossey","year":"2018","journal-title":"Trends Microbiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41467-017-00170-x","article-title":"Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor","volume":"8","author":"Roymans","year":"2017","journal-title":"Nat. Commun."},{"key":"B181","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B182","doi-asserted-by":"publisher","first-page":"e0130378","DOI":"10.1371\/journal.pone.0130378","article-title":"Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections","volume":"10","author":"Salez","year":"2015","journal-title":"PLoS ONE"},{"key":"B183","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/107327481602300416","article-title":"Human metapneumovirus infection in immunocompromised patients","volume":"23","author":"Samuel","year":"2016","journal-title":"Cancer Control"},{"key":"B184","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/cmr.00015-11","article-title":"Human metapneumovirus: lessons learned over the first decade","volume":"24","author":"Schildgen","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B185","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbmt.2012.12.019","article-title":"Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement","volume":"19","author":"Seo","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B186","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/cid\/ciw284","article-title":"Human metapneumovirus infections following hematopoietic cell transplantation: factors associated with disease progression","volume":"63","author":"Seo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3324\/haematol.2016.153767","article-title":"Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality","volume":"102","author":"Seo","year":"2017","journal-title":"Haematologica"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/cid\/ciu134","article-title":"Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome","volume":"58","author":"Seo","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1182\/blood-2013-12-541359","article-title":"Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections","volume":"123","author":"Shah","year":"2014","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.bbmt.2015.11.338","article-title":"An open label, block-randomized, ribavirin efficacy trial for management of RSV infections in Hematopoietic Cell Transplant (HCT) recipients: clinical and economic implications","volume":"22","author":"Shah","year":"","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B191","first-page":"203","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients","volume":"2","author":"Shah","year":"2012","journal-title":"Am. J. Blood Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.canlet.2015.11.014","article-title":"Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review","volume":"370","author":"Shah","year":"","journal-title":"Cancer Lett."},{"key":"B193","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2016.05.035","article-title":"Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review","volume":"379","author":"Shah","year":"","journal-title":"Cancer Lett."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2010-08-263400","article-title":"Management of RSV infections in adult recipients of hematopoietic stem cell transplantation","volume":"117","author":"Shah","year":"2011","journal-title":"Blood"},{"key":"B195","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/14787210.2017.1279970","article-title":"Antiviral therapy for respiratory viral infections in immunocompromised patients","volume":"15","author":"Shahani","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1128\/aac.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B197","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/INF.0b013e31821d190f","article-title":"Parainfluenza virus infections in children with hematologic malignancies","volume":"30","author":"Srinivasan","year":"","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.bbmt.2011.03.001","article-title":"Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation","volume":"17","author":"Srinivasan","year":"","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B199","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/infdis\/jiy227","article-title":"Antiviral activity of oral JNJ-53718678 in healthy adult volunteers challenged with respiratory syncytial virus: a placebo-controlled study","volume":"218","author":"Stevens","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B200","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jpeds.2017.08.071","article-title":"The effectiveness of trivalent inactivated influenza vaccine in children with acute leukemia","volume":"191","author":"Sykes","year":"2017","journal-title":"J. Pediatr."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1128\/aac.04939-14","article-title":"Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses","volume":"59","author":"Tamura","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B202","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/08880018.2015.1013230","article-title":"One-year prospective study of community acquired influenza and parainfluenza viral infections in hospitalized egyptian children with malignancy: single center experience","volume":"32","author":"Tantawy","year":"2015","journal-title":"Pediatr. Hematol. Oncol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/s41467-017-01858-w","article-title":"Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein","volume":"8","author":"Tian","year":"2017","journal-title":"Nat. Commun."},{"key":"B204","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2017.10.002","article-title":"The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide","volume":"147","author":"Tilmanis","year":"2017","journal-title":"Antiviral Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B206","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/cmr.00032-09","article-title":"Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology","volume":"23","author":"Tregoning","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B207","doi-asserted-by":"publisher","first-page":"e7838","DOI":"10.1371\/journal.pone.0007838","article-title":"Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"","journal-title":"PLoS ONE"},{"key":"B208","doi-asserted-by":"publisher","first-page":"e7788","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer","year":"","journal-title":"PLoS ONE"},{"key":"B209","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/infdis\/jix358","article-title":"Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy","volume":"216","author":"Tzannou","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B210","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1128\/jvi.00318-06","article-title":"Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo","volume":"80","author":"Ulbrandt","year":"2006","journal-title":"J. Virol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.bbmt.2012.04.012","article-title":"Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time","volume":"18","author":"Ustun","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B212","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"van der Hoek","year":"2007","journal-title":"Antivir. Ther."},{"key":"B213","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1034\/j.1600-6143.2003.00024.x","article-title":"Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function","volume":"3","author":"Vilchez","year":"2003","journal-title":"Am. J. Transplant"},{"key":"B214","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1086\/324348","article-title":"The epidemiology of parainfluenza virus infection in lung transplant recipients","volume":"33","author":"Vilchez","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/cid\/cit639","article-title":"Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes","volume":"57","author":"Waghmare","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B216","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2016-01-634873","article-title":"How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation","volume":"127","author":"Waghmare","year":"2016","journal-title":"Blood"},{"key":"B217","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/jpids\/piu039","article-title":"Successful treatment of parainfluenza virus respiratory tract infection with DAS181 in 4 immunocompromised children","volume":"4","author":"Waghmare","year":"2015","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"B218","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1086\/513976","article-title":"Severity of respiratory syncytial virus infection is related to virus strain","volume":"175","author":"Walsh","year":"1997","journal-title":"J. Infect. Dis."},{"key":"B219","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/infdis\/jiy106","article-title":"Virus-specific antibody, viral load, and disease severity in respiratory syncytial virus infection","volume":"218","author":"Walsh","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/656802","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial","volume":"51","author":"Watanabe","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B221","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1399-3062.2010.00493.x","article-title":"Influenza A\/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure","volume":"12","author":"Watcharananan","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"B222","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1055\/s-0031-1283286","article-title":"Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients","volume":"32","author":"Weigt","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B223","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinids\/22.5.778","article-title":"Community respiratory virus infections among hospitalized adult bone marrow transplant recipients","volume":"22","author":"Whimbey","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"B224","first-page":"393","article-title":"Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients","volume":"16","author":"Whimbey","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"B225","first-page":"16","article-title":"Community respiratory virus infections in immunocompromised patients with cancer","volume":"25","author":"Whimbey","year":"1997","journal-title":"Am. J. Med."},{"key":"B226","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/649875","article-title":"Preferential lower respiratory tract infection in swine-origin 2009 A(H1N1) influenza","volume":"50","author":"Yeh","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B227","doi-asserted-by":"publisher","first-page":"eaaj1928","DOI":"10.1126\/scitranslmed.aaj1928","article-title":"A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants","volume":"9","author":"Zhu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B228","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1128\/jcm.00360-17","article-title":"Investigation of respiratory syncytial virus outbreak on an adult stem cell transplant unit by use of whole-genome sequencing","volume":"55","author":"Zhu","year":"2017","journal-title":"J. Clin. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.03097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:36:07Z","timestamp":1775302567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.03097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":228,"alternative-id":["10.3389\/fmicb.2018.03097"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.03097","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]},"article-number":"3097"}}